Legal Representation
Attorney
Frances M. Jagla
USPTO Deadlines
Next Deadline
59 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
September 26, 2025
Extension Available
Until September 26, 2024
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 11, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 11, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 10, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 10, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 20, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 20, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 20, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 20, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 12, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 12, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 26, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 1, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 1, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 12, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 27, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 27, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 27, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 27, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 27, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 25, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 21, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 7, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders
Class 042
Medical research and medical research information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
Class 044
Providing healthcare information to healthcare professionals and patients relating to the disease state and treatment options; Medical information services in the fields of pharmaceuticals, oncology, and blood diseases and disorders
Classification
International Classes
005
042
044